Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
EJNMMI Radiopharmacy and Chemistry|March 26, 2024
Expanding a peptide-covalent probe hybrid for PET imaging of S. aureus driven focal infectionsJyotsna Bhatt Mitra, Saurav Chatterjee, Anuj Kumar, et al.
Clinical Nuclear Medicine|March 5, 2019
Differential Uptake of 68Ga-PSMA-HBED-CC (PSMA-11) in Low-Grade Versus High-Grade Gliomas in Treatment-Naive PatientsPriyanka Verma, Gaurav Malhotra, Atul Goel, et al.
Drug Development Research|December 11, 2023
Exploring the potential of radiolabeled duramycin as an infection imaging probeAnuj Kumar, Jyotsna Bhatt Mitra, Elina Khatoon, et al.
Journal of Medicinal Chemistry|January 14, 2025
Chlorambucil Conjugation Enhances the Potency of Rituximab: Synthesis and Evaluation of the Novel [177Lu]Lu-Labeled Rituximab-Chlorambucil Conjugate toward Therapy of Non-Hodgkin's LymphomaNaveen Kumar, Shishu Kant Suman, Mohini Guleria, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 24, 2025
Protein-functionalized and intrinsically radiolabeled [188Re]ReOx nanoparticles: advancing cancer therapy through concurrent radio-photothermal effectsSanchita Ghosh, Apurav Guleria, Sourav Patra, et al.
Drug Development Research|August 12, 2023
Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI-derived octapeptideJyotsna Bhatt Mitra, Archana Mukherjee, Anuj Kumar, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 17, 2021
Therapeutic Multidose Preparation of a Ready-to-Use 177Lu-PSMA-617 Using Carrier Added Lutetium-177 in a Hospital Radiopharmacy and Its Clinical EfficacyAvik Chakraborty, Arpit Mitra, Megha Tawate, et al.
Molecular Pharmaceutics|March 13, 2024
Nuclear Localization Signal Enhances the Targeting and Therapeutic Efficacy of a Porphyrin-Based Molecular Cargo: A Systemic In Vitro and Ex Vivo EvaluationNaveen Kumar, Amit K Sharma, Mohini Guleria, et al.
Bioconjugate Chemistry|June 28, 2023
Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior VariantAmit Kumar Sharma, Rohit Sharma, Amit Das, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 16, 2022
Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor OverexpressionSreeja Raj Menon, Arpit Mitra, Avik Chakraborty, et al.
Pageof 3